Brazilian Journal of Pharmaceutical Sciences · 2013 · 24 citations · 20 references
PharmacyPharmaceuticsPharmacologyControlled Release FormulationsDrug DeliveryPharmaceutical FormulationDissolution-controlled ReleaseDrug Release From Dosage FormsDrug Release KineticsGelsHydrogelsPolymeric Drug Delivery SystemsBiopharmaceutical Property AssessmentControlled ReleaseDissolution ProcessesDrug Delivery HydrogelsHydrogel CharacterizationHydrogel Drug ReleaseHydrogel FormulationsSwelling
A hydrogel was developed from 70 kDa dextran (DEX-70) and praziquantel (PZQ) incorporated as a model drug. Biopharmaceutical properties, such as solubility and dissolution rate, were analysed in the design of the hydrogel. Furthermore, the hydrogel was also characterized by IR spectroscopy and DSC. Tests of the swelling rate showed that the hydrogel swelled slowly, albeit faster than the rate for the free polymer. In dissolution tests, the hydrogel released the drug slowly and continuously. This slow release was similar to that observed in the swelling tests and resulted in controlled release of the drug. Thus, this dextran is a suitable polymer for the development of hydrogels as vehicles for the controlled release of drugs.
20
S. Breda, Alvaro F. Jimenez‐Kairuz, Rubén H. Manzo et al. · International Journal of Pharmaceutics · 2008 · 146 citations
Martin Johannes Enk, Anna Carolina Lustosa Lima, Sandra Drummond et al. · Acta Tropica · 2008 · 142 citations · Full text